New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy.
Claudia FabianiJurgen SotaMaite Sainz de La MazaLaura PelegrínGiacomo EmmiGiuseppe LopalcoFlorenzo IannoneLorenzo VannozziSilvana GuerrieroMaria Chiara GelmiDonato RiganteGian Marco TosiJosé Hernández-RodríguezClaudia FabianiPublished in: Mediators of inflammation (2020)
Our results, though limited to a low number of patients, highlight the effectiveness of different biologic therapies in the treatment of noninfectious refractory scleritis, showing to control scleral inflammation and allowing a significant reduction in the number of relapses.